STOCK TITAN

Mitesco CEO Brian Valania receives 3M-share award

Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no Common Stock underlying it.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Mitesco, Inc. (MITI) CEO and CFO Brian Valania reported direct grant or award acquisitions of 3,000,000 common shares on August 3, 2026, at $0.035 per share; 221,078 on July 21, 2026, at $0.08 per share; 83,334 on October 26, 2025, at $0.035 per share; and 200,000 on July 29, 2024, at $0.25 per share. His Series X Preferred awards included 4,800 shares on November 5 and July 10, 2026, and 2,400 shares on May 1, 2026. Each Series X share has a $400 stated value.

Insider Valania Brian
Role CEO and CFO
Type Security Shares Price Value
Grant/Award Series X Pref. F1 4,800 $400.00 $1.92M
Grant/Award Common Stock 3,000,000 $0.035 $105K
Grant/Award Common Stock 221,078 $0.08 $18K
Grant/Award Series X Pref. F1 4,800 $400.00 $1.92M
Grant/Award Series X Pref. F1 2,400 $400.00 $960K
Grant/Award Common Stock 83,334 $0.035 $3K
Grant/Award Common Stock 200,000 $0.25 $50K
Holdings After Transaction: Series X Pref. — 12,000 (Direct); Common Stock — 3,421,078 shares (Direct)
Holdings Before and After: Series X Pref., 0 to 12,000 (Direct)
Footnotes (1)
  1. F1. The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it.
Common shares awarded 3,000,000 shares August 3, 2026
Per-share price $0.035 per share Common Stock award on August 3, 2026
Common shares awarded 221,078 shares July 21, 2026
Per-share price $0.08 per share Common Stock award on July 21, 2026
Series X Preferred shares awarded 4,800 shares November 5, 2026
Series X Preferred stated value $400 per share Series X Preferred Stock
Series X Preferred shares awarded 4,800 shares July 10, 2026
Series X Preferred shares awarded 2,400 shares May 1, 2026
Series X Preferred Stock technical
"The Series X Preferred Stock has no conversion rights"
Series X preferred stock is a specific class of company shares that gives holders priority over common shareholders for dividend payments and payout if the company is liquidated, often with a set dividend rate or special conversion or voting terms. Think of it as a VIP ticket in line: it usually offers more income stability and protection but less upside from stock price gains, so investors weigh steady returns and safety against limited growth potential.
conversion rights technical
"has no conversion rights"
Conversion rights are a contract feature that lets the holder change one kind of security—often a bond or preferred share—into another, typically common stock, at a predetermined rate. Investors care because conversion can provide upside if the stock rises (like swapping a ticket for a better prize), but it can also dilute existing shareholders and change ownership and voting power, affecting share value and strategy.
stated value financial
"Series X has a $400 stated value"
Stated value is an accounting figure a company assigns to a share when the share has no par (legal) value; it becomes the portion of proceeds recorded as the company’s permanent capital for regulatory and bookkeeping purposes. It matters to investors because it affects the equity reported on the balance sheet and the legal limits on distributions or dividend payments, but it is not the market price — think of it as a record-keeping sticker price rather than what buyers actually pay.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many common shares did MITI CEO and CFO Brian Valania receive in the 2026 awards?

Brian Valania received direct awards of 3,000,000 common shares on August 3, 2026, at $0.035 per share and 221,078 common shares on July 21, 2026, at $0.08 per share.

Can MITI's Series X Preferred Stock convert into common shares?

No. Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Valania Brian

(Last)(First)(Middle)
505 BEACHLAND BLVD.
SUITE 1-377

(Street)
VERO BEACH FLORIDA 32963

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Mitesco, Inc. [ MITI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2024
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/29/2024A200,000A$0.25200,000D
Common Stock07/21/2026A221,078A$0.08421,078D
Common Stock08/03/2026A3,000,000A$0.0353,421,078D
Common Stock10/26/2025A83,334A$0.0353,504,412D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series X Pref.(1)05/01/2026A2,400 (1) (1)Common0$4002,400D
Series X Pref.(1)07/10/2026A4,800 (1) (1)Common0$4007,200D
Series X Pref.(1)11/05/2026A4,800 (1) (1)Common0$40012,000D
Explanation of Responses:
1. The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it.
Remarks:
Board-approved grants. The 07/10/26 common grant increased direct ownership to 421,078 shares; the 08/03/26 common grant increased it to 3,421,078 shares. The 07/10/26 Series X grant increased direct ownership to 7,200 preferred shares. Series X has a $400 stated value; conversion terms and underlying common shares remain subject to counsel review. The 10/26/25 common stock issuance added 83,334 shares at $0.035 per share, increasing direct ownership to 3,504,412 shares. The 11/05/26 Series X Preferred issuance added 4,800 shares, increasing direct ownership to 12,000 preferred shares.
/s/ Brian Valania11/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading